James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

3 Big Stock Charts for Thursday: DISH Network, American Airlines Group and Kellogg

The stock charts of K, DISH and AAL are knocking on the doors of major moves, if they can just cross a couple more things off the checklist.

Buy Bank of America Stock Before Its Good Citizenship Pays Off

Bank of America stock was always a solid holding, but civic-minded efforts are quickly making this name a must-have.

Avenatti’s Bribery Claims Won’t Really Hurt Nike Stock

Nike stock has been kicked around a bit in the wake of a fresh scandal, but this is hardly a damning accusation.

3 Big Stock Charts for Wednesday: Incyte, FMC and LyondellBasell

The stock charts of INCY, LYB and FMC are going to start this week's hump-day at a precipice. Here are the numbers to know.

10 Dow Jones Stocks Holding the Blue Chip Index Back

Pfizer, Walgreens and Merck are just three of the Dow Jones stocks that have kept the index from doing as well as other market indices have this year.